cabecera

 

Urolitiasis

 

Portal de información sobre litiasis del aparato urinario
 
menu

Urolitiasis

Inicio

Ensayos clínicos

Meta-análisis

Guías Clínicas

Webcasts Congresos

Información pacientes

Temas:

Recursos generales

Epidemiología

Cólico renal

Metabolismo

Diagnóstico imagen

Litiasis vesical

Tto. médico

Litotricia extracorpórea

Ureteroscopia

Nefrolitotomía percutánea

Cirugía abierta

Cirugía laparoscópica

Litiasis en pediatría

Litiasis y embarazo

Publicidad

 
 

Urolitiasis - Litiasis vesical

Tratamiento médico de la litiasis urinaria

 

 

 

"Urolithiasis/diet therapy"[Majr] OR "Urolithiasis/drug therapy"[Majr]:

 

  • [Use of alfuzosin for expulsion of stones in the distal third of ureter]
    Related Articles

    [Use of alfuzosin for expulsion of stones in the distal third of ureter]

    Actas Urol Esp. 2009 Oct;33(9):1005-10

    Authors: García Morúa A, Gutiérrez García JD, Martínez Montelongo R, Gómez Guerra LS

    INTRODUCTION: Ureteral stones occur in approximately 12% of the population worldwide, and their incidence has significantly increased in recent years in Western countries. Seventy percent of ureteral stones are located in the distal third of the ureter. Several factors have a strong influence on spontaneous passage of ureteral stones, including stone size, shape, and location. Alpha blockers are currently attributed a potential role in rapid expulsion of stones in the distal third of the ureter. MATERIALS AND METHODS: Thirty patients diagnosed of stones in the distal third of ureter of sizes ranging from 4 mm and 10 mm were divided into two groups. The first group was given Buscopan 10 mg plus ketorolac 10 mg every 8 hours, while the second group received alfuzosin 10 mg every 24 hours. RESULTS: In group 1, mean stone size was 6.4 mm. Stone expulsion occurred in only 4 patients after a mean of 11.4 days. In group 2, mean stone size was 5.8 mm, and stone expulsion occurred in 13 patients after a mean of 3.3 days.The two stones that were not passed where the biggest ones (9 mm and 10 mm). CONCLUSIONS: Use of alpha-adrenergic blockers for ureteral distal third stones has been shown to be effective for increasing the stone expulsion rate and even the number of stones passed, and for faster symptom relief.

    PMID: 19925762 [PubMed - indexed for MEDLINE]


 

Google
 
Web www.uroportal.net
derecho

Publicidad

 
pie
 

Actualizada el 28/10/2008

 

uroportal@uroportal.net

Nosotros subscribimos Los Principios del código HONcode de la Fundación 
Salud en la Red

 

Nosotros subscribimos los Principios del código HONcode.

 Compruébelo aquí

+info

  Sello de calidad Medicina XXI